...Caesarian section, infiltration shoulder surgery, juvenile epidural surgery, post-operative pain control and cancer pain control. Chiroscience Group plc...

...research is in small molecules, as it acquired these capabilities in its 1999 mergers with Chiroscience Group plc...

...it will close its drug discovery facility in Seattle, which it inherited with the 1999 Chiroscience...

...to increase our critical mass.” Doing that quickly meant making an acquisition, and in 1999 Chiroscience Group plc...
...Cambridge, U.K.) was the logical choice. “British Biotech was already a big problem company. But Chiroscience...
...6/15/99 - Chiroscience merger announcement; CCH 6/14/99 mkt cap = £364.8M ($591M) B. 8/6/99 - Chiroscience...

...an M&A standpoint," he said. CCH reached its current stage of development by merging with Chiroscience Group plc...

...also took part in the £331 million ($535 million) merger of Celltech (CCH; CLL) and Chiroscience...

...U.K.). CCH reached its current market cap of £944 million ($1.6 billion) by merging with Chiroscience Group plc...

...Akubio Ltd. , Cambridge, U.K. Business: Diagnostics/Imaging Appointed: John Padfield, former CEO of Chiroscience Group plc , as...

...see BioCentury, Dec. 3, 2001). The deal also bears similarities to the 1999 acquisition of Chiroscience Group plc...
...for £563 million ($912 million) in another stock swap (see BioCentury, Nov. 15, 1999). "The Chiroscience...
...Celltech to acquire Medeva," Scott told BioCentury. "Celltech did not get a lot out of Chiroscience...